Antigenics antigenics.com


Antigenics (NASDAQ: AGEN) is a biotechnology company working to develop treatments for cancers and infectious diseases.

Antigenics (NASDAQ: AGEN) is a biotechnology company working to develop treatments for cancers and infectious diseases.

Company (IPO / Went public)

Phone: 781-674-4400

Fax: 781.674.4200

3 Forbes Road

Lexington, 02421
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Antigenics $26.1M Jan 9, 2008
Ecopia BioSciences $0M Mar 14, 2007
Cyclacel Pharmaceuticals $245.4M Apr 21, 2006
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Antigenics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Characterization of granulocytic ehrlichia and methods of use Jan 09, 2012 Jun 11, 2013 Patent
Characterization of granulocytic ehrlichia and methods of use Jun 25, 2012 May 07, 2013 Patent
Characterization of granulocytic ehrlichia and methods of use Aug 18, 2010 Jan 10, 2012 Patent
Characterization of granulocytic Feb 26, 2001 Jan 04, 2011 Patent
Compositions of cpg and saponin adjuvants and uses thereof Mar 10, 2006 Dec 28, 2010 Patent